Metabolic engineering for microbial production of terpenoid products

Inventors

KUMARAN, Ajikumar Parayil • LIM, Ryan • Donald, Jason • TSENG, Hsien-Chung • Santos, Christine • PHILIPPE, Ryan

Assignees

Manus Bio Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-10480015-B2

Patent

Publication Date

2019-11-19

Expiration Date


Abstract

The invention relates to methods and bacterial strains for making terpene and terpenoid products, the bacterial strains having improved carbon pull through the MEP pathway and to a downstream recombinant synthesis pathway.

Core Innovation

The disclosed method produces a terpene or terpenoid product by culturing an E. coli bacterial strain that synthesizes IPP and DMAPP through an upstream MEP pathway and converts them via a recombinant downstream synthesis pathway. The strain overexpresses IspG and IspH and comprises recombinant PFOR that enhances the supply or transfer of electrons. In one independent claim, IspH activity is higher than IspG activity to increase carbon flux to HMBPP while preventing feedback-reducing intermediate accumulation.

Accumulation of HMBPP and related intermediates is identified as a bottleneck and feedback mechanism that reduces MEP pathway flux and product productivity. Pathway engineering modifications, including aceE deletion or mutation to reduce PDH activity, complementation with PFOR and flavodoxin homologs, and balanced enzyme overexpression, redirect carbon and electron flux to lower intermediate accumulation and enhance target product titers.

Claims Coverage

The claims identify two independent claims covering the production of a terpene or terpenoid product in an E. coli strain, encompassing five inventive features.

Upstream MEP and recombinant downstream synthesis pathways

Claims 1 and 35 recite an E. coli bacterial strain that produces IPP and DMAPP through an upstream MEP pathway and converts them to a terpene or terpenoid product through a recombinant downstream synthesis pathway.

Overexpression of IspG and IspH

Claims 1 and 35 recite overexpressing IspG and IspH in the bacterial strain by complementation with recombinant ispG and ispH genes.

Higher IspH activity relative to IspG activity

Claim 1 specifies that IspH activity is higher than IspG activity to provide increased carbon flux to HMBPP while preventing HMBPP accumulation at an amount that feeds back and reduces MEP pathway flux and terpene or terpenoid productivity.

Recombinant PFOR expression

Both independent claims require recombinant PFOR in the bacterial strain, wherein claim 1 further specifies that PFOR enhances the supply or transfer of electrons through the MEP pathway or to terpene and terpenoid products.

Culturing the bacterial strain

Claims 1 and 35 recite culturing the engineered bacterial strain to produce the terpene or terpenoid product.

Together, the independent claims cover methods of culturing an engineered E. coli strain comprising an MEP pathway, a recombinant downstream synthesis pathway, overexpressed IspG and IspH, and recombinant PFOR to produce a terpene or terpenoid product, with claim 1 additionally requiring higher relative IspH activity to avoid feedback-reducing HMBPP accumulation.

Stated Advantages

Balancing or increasing IspH activity relative to IspG activity increases carbon flux to HMBPP while avoiding feedback inhibition, achieving over threefold higher product titers.

Recombinant PFOR, tested PFOR homologs, and electron-transfer tuning such as flavodoxin enhance electron supply and transfer to improve terpenoid production.

Reducing PDH activity through aceE knockout or mutation increases product titers and reduces MEP pathway intermediate concentrations, including extracellular MEcPP.

Overexpression of PgpB increases farnesol titers up to approximately threefold.

Documented Applications

Production of terpene or terpenoid products, including farnesene, amorphadiene, artemisinic acid, artemisinin, bisabolol, geraniol, limonene, steviol glycosides, taxadiene, and valencene.

Incorporation of microbially produced terpenes or terpenoids into industrial or consumer products, including flavor products, fragrance products, sweeteners, cosmetics, cleaning products, detergents or soaps, and pest control products.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.